OTCMKTS:CBDS Cannabis Sativa (CBDS) Stock Price, News & Analysis $0.01 0.00 (0.00%) (As of 10/23/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest About Cannabis Sativa Stock (OTCMKTS:CBDS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cannabis Sativa alerts:Sign Up Key Stats Today's Range$0.0107▼$0.013850-Day Range$0.0040▼$0.013952-Week Range$0.00▼$0.03Volume663,614 shsAverage Volume205,759 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.Read More… Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Cannabis Sativa Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks12th Percentile Overall ScoreCBDS MarketRank™: Cannabis Sativa scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cannabis Sativa.Read more about Cannabis Sativa's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cannabis Sativa is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cannabis Sativa is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoverCannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cannabis Sativa has recently decreased by 96.55%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCannabis Sativa does not currently pay a dividend.Dividend GrowthCannabis Sativa does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverCannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cannabis Sativa has recently decreased by 96.55%, indicating that investor sentiment is improving significantly. News and Social Media1.3 / 5News SentimentN/A News SentimentCannabis Sativa has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cannabis Sativa this week, compared to 2 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cannabis Sativa insiders have not sold or bought any company stock.Percentage Held by Insiders27.46% of the stock of Cannabis Sativa is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Cannabis Sativa's insider trading history. Receive CBDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannabis Sativa and its competitors with MarketBeat's FREE daily newsletter. Email Address CBDS Stock News Headlines70% Of German Physicians Can Now Prescribe Reimbursed Medical Marijuana, More Cannabis Updates From Italy And JapanOctober 21 at 9:47 AM | benzinga.comGary Payton THCA Flower Strain: Black Tie CBD's New High-Potency Hemp DelightOctober 12, 2024 | markets.businessinsider.comtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.October 24, 2024 | Traders Agency (Ad)Dabney: My journey with cannabisOctober 9, 2024 | startribune.comState urges judge to reject lawsuit targeting new hemp regulationsOctober 4, 2024 | yahoo.comCannabis Has Become Upscale Chic. I Miss the Old Red-Eyed Stoners.October 1, 2024 | nytimes.com'No Companies Will Invest': How California's Hemp Rules Could Hurt Cannabis BusinessesSeptember 30, 2024 | benzinga.comDEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of ReschedulingSeptember 24, 2024 | benzinga.comSee More Headlines CBDS Stock Analysis - Frequently Asked Questions How have CBDS shares performed this year? Cannabis Sativa's stock was trading at $0.0090 on January 1st, 2024. Since then, CBDS shares have increased by 44.4% and is now trading at $0.0130. View the best growth stocks for 2024 here. How do I buy shares of Cannabis Sativa? Shares of CBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cannabis Sativa own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Sativa investors own include Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), 22nd Century Group (XXII) and Sangamo Therapeutics (SGMO). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryCannabis Current SymbolOTCMKTS:CBDS CUSIPN/A CIK1360442 Webwww.cannabissativainc.com Phone(702) 762-3123FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (OTCMKTS:CBDS) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannabis Sativa, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cannabis Sativa With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.